| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.0007 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |